HomeNewsBusinessCompaniesCarlyle Group buys 37% stake in Metropolis Healthcare

Carlyle Group buys 37% stake in Metropolis Healthcare

An affiliate of Carlyle Asia Partners IV has bought a stake in Metropolis Healthcare Ltd, a multinational chain of pathology laboratories, Carlyle Group said in a statement.

September 10, 2015 / 11:26 IST
Story continues below Advertisement

Global private equity firm Carlyle Group has acquired 37 percent stake in diagnostic chain Metropolis Healthcare by buying out the share of its promoter GSK Velu and his affiliates for an undisclosed sum.

An affiliate of Carlyle Asia Partners IV has bought a stake in Metropolis Healthcare Ltd, a multinational chain of pathology laboratories, Carlyle Group said in a statement.

Story continues below Advertisement

While Carlyle Group did not disclose details of the transaction, including the stake it had acquired in Metropolis, industry sources said it has bought "the entire 37 percent stake" held by GSK Velu and his affiliates.

Commenting on the development, Carlyle Asia Buyout Team Managing Director Neeraj Bharadwaj said, "We are delighted to partner with Metropolis and back its promoter as well as its management team, and will leverage our healthcare industry expertise to support the company's growth plans."